Search Results - "Hoener, M.C."
-
1
Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: Role of D2 dopamine autoreceptors
Published in Neuropharmacology (01-06-2014)“…Trace Amine-Associated Receptor 1 (TAAR1) is a G protein-coupled receptor (GPCR) expressed in several mammalian brain areas and activated by “trace amines”…”
Get full text
Journal Article -
2
Monoamine transporter and receptor interaction profiles of novel phenethylamine derivatives
Published in European neuropsychopharmacology (01-10-2016)Get full text
Journal Article -
3
S.04.04 TAAR1: from endogenous to selective agonists for the treatment of schizophrenia
Published in European neuropsychopharmacology (01-10-2014)Get full text
Journal Article -
4
Dopamine transporter knockout rats as a novel model of dopamine associated disorders
Published in European neuropsychopharmacology (01-10-2016)Get full text
Journal Article -
5
P.1.h.027 Dopamine transporter knockout rats: new experimental model in behavioral psychopharmacology research
Published in European neuropsychopharmacology (01-10-2014)Get full text
Journal Article -
6
P.1.g.030 Pronounced dopaminergic dysregulation in dopamine transporter knockout rats
Published in European neuropsychopharmacology (01-10-2014)Get full text
Journal Article -
7
P.1.d.014 Altered effects of apomorphine in TAAR1 knockout mice
Published in European neuropsychopharmacology (01-10-2012)Get full text
Journal Article -
8
-
9
Monoamine transporter and receptor interaction profiles of a new series of designer cathinones
Published in Neuropharmacology (01-04-2014)“…Psychoactive β-keto amphetamines (cathinones) are sold as “bath salts” or “legal highs” and recreationally abused. We characterized the pharmacology of a new…”
Get full text
Journal Article -
10
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight
Published in Molecular psychiatry (01-05-2013)“…Schizophrenia is a chronic, severe and highly complex mental illness. Current treatments manage the positive symptoms, yet have minimal effects on the negative…”
Get full text
Journal Article -
11
P.1.g.036 - Monoamine transporter and receptor interaction profiles of novel phenethylamine derivatives
Published in European neuropsychopharmacology (01-10-2016)Get full text
Journal Article -
12
Partial cortical devascularization results in elevations of cortical nerve growth factor and increases nerve growth factor protein within basal forebrain cholinergic neurons
Published in Neuroscience (01-04-1998)“…Previous studies have demonstrated that partial cortical devascularization results in increased levels of nerve growth factor protein within the tissue…”
Get full text
Journal Article -
13
P.1.h.011 - Dopamine transporter knockout rats as a novel model of dopamine associated disorders
Published in European neuropsychopharmacology (01-10-2016)Get full text
Journal Article -
14
Isolation and characterization of a phosphatidylinositol-glycan-anchor-specific phospholipase D from bovine brain
Published in European journal of biochemistry (05-07-1990)“…In recent years an increasing number of proteins has been shown to be membrane‐anchored by a covalently attached PtdIns‐glycan residue. In mammalian cells…”
Get full text
Journal Article